WIRT v. VEEVA SYSTEMS, INC.

CourtDistrict Court, E.D. Pennsylvania
DecidedMay 29, 2025
Docket2:23-cv-04949
StatusUnknown

This text of WIRT v. VEEVA SYSTEMS, INC. (WIRT v. VEEVA SYSTEMS, INC.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
WIRT v. VEEVA SYSTEMS, INC., (E.D. Pa. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

ALANA WIRT : : CIVIL ACTION v. : No. 23-4949 : VEEVA SYSTEMS, INC. :

McHUGH, J. May 29, 2025 MEMORANDUM After working in sales at Veeva Systems for over four years, Plaintiff Alana Wirt was terminated in March 2023, something she did not expect. She now sues Veeva, alleging that her termination was based on her gender and a medical condition Veeva did not accommodate. As to the former, she makes broad-sweeping allegations about Veeva’s “boys club culture” and male- dominated leadership. As to the latter, she claims she was stigmatized for her inability to engage in the company’s late night party culture. But there is undisputed evidence that she was consistently ranked near the bottom of her sales group, and she fails to identify any specific evidence of discrimination based on a protected characteristic. Because no reasonable jury could on this record infer either unlawful discrimination or a failure to reasonably accommodate her disability, Veeva is entitled to summary judgment. I. Relevant Facts Veeva Systems (“Veeva”) is a tech company that develops and sells cloud-based software for life sciences and consumer product industries. In 2018, Veeva hired Plaintiff Alana Wirt as a sales account executive, recruiting her from a different company. Offer Letter, ECF 19-5; Wirt Dep. 63:20-64:3, 65:14-19, ECF 19-3. During her entire tenure at Veeva, Ms. Wirt worked remotely, visiting her clients in-person as needed. Wirt Dep. 74:20-78:11. There were, however, several large in-person Veeva events

that Ms. Wirt ordinarily attended. At the beginning of each year, Veeva hosted a three-day field kickoff conference for all their sales and services staff, featuring various workshops and conference sessions. Id. 147:2-148:15; Smith Dep. 10:15-16:13, ECF 19-8. In the fall, Veeva hosted a two-day Summit attended by approximately 2,000 Veeva customers and employees. Smith Dep. 16:15-20:11. And a few times a year, sales teams met for Quarterly Business Reviews (“QBRs”), where account partners updated each other on their account plans, goals, and progress. Id. 20:12-21:12. At these in-person events, many attendees stayed out late in the evenings, socializing and drinking. A. The Impact of COVID-19 on Veeva’s Policies. Like most workplaces, Veeva shut down its offices and ceased most in-person work events

during the COVID-19 pandemic. Wirt Dep. 75:15-76:25. In early 2022, Veeva began to allow employees to return to their offices. Id. But to address the continued risk of COVID-19, Veeva adopted a temporary vaccine mandate, requiring sales employees – even those who primarily worked remotely like Ms. Wirt – to be vaccinated. Id. 75:15-77:12. Ms. Wirt, who suffers from Hashimoto’s thyroiditis, requested a medical exemption from Veeva’s vaccine mandate, supported by a letter from a physician.1 Id. 170:1-171:5; Physician Letter, ECF 19-6. After submitting the request and medical note to Veeva human resources in February 2022, Ms. Wirt’s supervisors told her that she couldn’t physically enter the office, but that she would not be disciplined for remaining

1 Ms. Wirt’s primary care physician recommended that she obtain a COVID-19 vaccine, but she pursued a second “unbiased opinion” from a physician who was recommended for his “nonmedical, non- pharmaceutical intervention.” Id. 172:10-174:13.

2 unvaccinated due to her medical condition. Wirt Dep. 176:3-177:19. Ms. Wirt never formally heard back from human resources about her exemption. Id. But she personally does not appear to

have followed up with human resources, trusting her supervisors’ determination that she could remain unvaccinated due to her condition. Id. Significantly, Ms. Wirt was never disciplined, demoted, denied a promotion, or experienced a pay decrease because of her vaccination status. Id. 179:19-180:4. She attended her team’s first 2022 QBR, located nearby in Radnor, Pennsylvania, remotely.2 Id. 133:25-134:11. She was invited to attend the off-site QBR team dinner and go-kart outing connected to that event, but chose not to. Id. 171:3-17. In fact, for the second 2022 QBR, Veeva rented an off-site office space so that Wirt could attend in-person and “build camaraderie” with her team, circumventing the vaccination policy that only applied to Veeva’s own offices. Id. 134:12-23. Veeva lifted its vaccine mandate in June or July 2022. Id. 77:9-10, 159:24-160:1. Ms.

Wirt continued to work remotely as she had since joining Veeva; the only difference was that she could now enter Veeva’s offices. Id. 180:5-15, 160:2-5. B. Ms. Wirt’s Roles and Performance at Veeva. At Veeva, Ms. Wirt initially worked on the Clinical Data Management Services (CDMS) team, selling a single Veeva product to both new and existing Veeva customers. Wirt Dep. 72:17- 73:18, 78:19-79:17. Starting in late 2021 Ms. Wirt began selling Veeva’s full suite of R&D applications. Id. 72:17-79:17. In February 2022 the entire CDMS team merged into Veeva’s R&D sales department and Ms. Wirt became an account partner on an R&D sales team managed by

2 One other member of Ms. Wirt’s team also attended this meeting remotely. Id. 134:7-11.

3 Adam De Oliveira. Id. In R&D, Ms. Wirt was responsible for selling every Veeva product. Id. 79:3-9; Compl. ¶ 12, ECF 1.

This transition was difficult – she acknowledges that being responsible for so many new products overwhelmed her. Wirt Dep. 228:3-229:17. Adam De Oliveira, her R&D manager at the time, noticed this, claiming that “she struggled also with [] the sheer volume of products that we have to sell . . . it was a lot more to manage, a lot more complex, and she struggled with that.” De Oliveira Dep. 37:8-13, ECF 19-7. According to Mr. De Oliveira, Ms. Wirt was still uncomfortable with the large number of products after a year on the team. De Oliveira Dep. 64:1-7. At her December 2022 Check-In, Mr. De Oliveira specifically wrote that “Alana wants to get more confident talking about Vault across the enterprise”). Id. Ex. 2. Ms. Wirt appears to have struggled in R&D in other ways as well. Mr. De Oliveira believed that she was overwhelmed with the normal account partner workload, and as a result, he assigned

some of her work to other partners to make it more manageable. Id. 36:8-10, 62:22-25. Ms. Wirt also struggled with a core aspect of working in sales at Veeva – generating new leads, also called “hunting” in industry terms. According to De Oliveira, Ms. Wirt “wasn’t prospecting, she wasn’t hunting, she was mostly just responding to whatever was going on with her accounts, which was good, but not good enough. Like, I really needed her to do more.” De Oliveira Dep. 36:11-15. As a result, her sales pipeline was “absolutely” below average. Id. 58:6. In her deposition, Ms. Wirt confirmed that she spent most of her time in 2022 and 2023 managing existing accounts, not prospecting new business. Wirt Dep. 82:23-83:5; see also id. 227:2-23 (after discussing feeling overwhelmed, Ms. Wirt was tasked with focusing on existing accounts in 2023 and having other

account partners do more prospecting).

4 In addition, De Oliveira concluded that he “could not trust her [sales] forecasts at all,” De Oliveira Dep. at 42:18-23, which was concerning because account partners’ forecasts feed into

Veeva’s external projections to Wall Street. Id. 68:1-4. Mr. De Oliveira found Ms. Wirt’s forecasts to be “painful, because she forecasted really high. So basically, she would say that she would have very high revenue and then come way, way, way below the forecast.” De Oliveira Dep. 42:18-25. This is corroborated by Ms. Wirt’s July 5, 2022 check-in, where it was addressed as a deficiency. De Oliveira Dep. 38:23-25; see id. Ex. 1. Ms.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sulima v. Tobyhanna Army Depot
602 F.3d 177 (Third Circuit, 2010)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Faragher v. City of Boca Raton
524 U.S. 775 (Supreme Court, 1998)
Francis J. Kelly v. Drexel University
94 F.3d 102 (Third Circuit, 1996)
Katherine L. Taylor v. Phoenixville School District
184 F.3d 296 (Third Circuit, 1999)
Gary L. Rinehimer v. Cemcolift, Inc
292 F.3d 375 (Third Circuit, 2002)
Sally J. Shellenberger v. Summit Bancorp, Inc
318 F.3d 183 (Third Circuit, 2003)
Margaret D. Conneen v. Mbna America Bank, N.A
334 F.3d 318 (Third Circuit, 2003)
Armstrong v. Burdette Tomlin Memorial Hospital
438 F.3d 240 (Third Circuit, 2006)
Colwell v. Rite Aid Corp.
602 F.3d 495 (Third Circuit, 2010)
Fredrick Capps v. Mondelez Global LLC
847 F.3d 144 (Third Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
WIRT v. VEEVA SYSTEMS, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/wirt-v-veeva-systems-inc-paed-2025.